Axogen, Inc. — Director's Dealing 2025

Dec 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-16

Reporting Person: Wendell Amy McBride (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-16	Common Stock	M	5000	$8.95	Acquired	98826	Direct
2025-12-16	Common Stock	M	20436	$6.30	Acquired	119262	Direct
2025-12-16	Common Stock	M	18248	$7.04	Acquired	137510	Direct
2025-12-16	Common Stock	S	5000	$29.312	Disposed	132510	Direct
2025-12-16	Common Stock	S	20436	$29.312	Disposed	112074	Direct
2025-12-16	Common Stock	S	18248	$29.312	Disposed	93826	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-16	Stock Option (right to purchase)	$8.95	M	5000	Disposed	2026-12-29	Common Stock (5000)	Direct
2025-12-16	Stock Option (right to purchase)	$6.30	M	20436	Disposed	2033-09-01	Common Stock (20436)	Direct
2025-12-16	Stock Option (right to purchase)	$7.04	M	18248	Disposed	2034-06-06	Common Stock (18248)	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Board of Directors' non-qualified stock option grant that vested in full May 26, 2017.

F3: Board of Directors' non-qualified stock option grant that vested in full September 1, 2024.

F4: Board of Directors' non-qualified stock option grant that vested in full June 6, 2025.